Association between the serum concentration of triiodothyronine with components of metabolic syndrome, cardiovascular risk, and diet in euthyroid post-menopausal women without and with metabolic syndrome

SpringerPlus

Table 3 Percentage and odds ratios (CI 95%) for metabolic syndrome (MetS) components and cardiovascular risk (CVR) in euthyroid post-menopausal women grouped considering the presence of MetS and triiodothyronine (T3) concentration

	Without MetS n=33	MetS-T3Q1 n=22	MetS-T3Q2 n=21	MetS-T3Q3 n=21	MetS-T3Q4 n=23
Waist circumference	30.3%	45.5%	66.7%	85.7%	82.6%
Waist circumference	REF	2.8 (0.8-9.7)	6.4 (1.7-23.5)**	16.2 (3.6-72.8)***	12.7 (3.0-53.3)***
Arterial tension	30.3%	72.7%	81.0%	61.9%	69.5%
Arterial tension	REF	5.7 (1.6-19.2)**	10.0 (2.6-38.6)***	4.1 (1.2-13.3)*	6.2 (1.8-21.0)**
Hyperglycemia	27.3%	95.5%	85.7%	66.7%	65.2%
Hyperglycemia	REF	53.8 (6.2-462.2)***	15.8 (3.7-67.4)***	5.4 (1.6-18.1)**	5.2 (1.6-16.9)**
Triglycerides	24.2%	72.7%	52.4%	57.1%	65.2%
Triglycerides	REF	8.0 (2.3-27.8)**	3.3 (1.0-10.9)*	4.2 (1.3-13.7)*	6.0 (1.8-19.6)**
Low HDL-C	54.5%	76.2%⁽²¹⁾	76.2%	95.2%	85.7% ⁽²¹⁾
Low HDL-C	REF	2.8 (0.8-9.5)	2.7 (0.8-9.2)	16.4 (1.9-137.6)*	4.9 (1.2-20.0)*
HOMA-IR	24.2%	36.3%	66.7%	66.7%	78.2%
HOMA-IR	REF	2.4 (0.6-8.5)	8.3 (2.2-30.5)***	6.8 (1.9-24.2)**	12.3 (3.2-47.1)***
CVR moderate/high	6.1%	45.5%⁽²¹⁾	52.4%	47.6%	19.0%⁽²¹⁾
CVR moderate/high	REF	14.6 (2.7-78.6)***	17.4 (3.2-92.9)***	14.0 (2.6-74.3)**	3.5 (0.5-21.7)

Binomial logistic regression was applied adjusting age was for all cases. HDL-C, HDL cholesterol; HOMA-IR, insulin resistance. *P ≤ 0.05, **P < 0.01, and ***P < 0.001. Note: HDL-C was not possible to be measure for all women. Numbers into superscript parenthesis together to prevalence for groups MetS-T3Q1 and MetS-T3Q4 indicate the number of participants for HDL-C and CVR.